What is known and objective Amiodarone, a commonly used class III antiarrhythmic agent
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

Acute hepatotoxicity is a rare adverse effect of intravenous administration of amiodarone, but
may be fatal if not recognized early and treated in a timely manner. Herein we report two …

Hepatotoxicity caused by chronic oral amiodarone is well documented with around 15-20%
incidence rate. However, acute liver failure due to intravenous (IV) amiodarone is rare …

A 73-year-old gentleman presented to the hospital after an episode of loss of
consciousness. He had a defibrillator in situ, which on interrogation was found to have fired …

Amiodarone is a drug which frequently causes elevated transaminases. However, acute
liver failure has been rarely reported. Here, we present a case of fatal acute liver failure …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …

Background Amiodarone is a highly effective treatment for supraventricular and ventricular
tachyarrhythmia; however, it could be associated with several serious adverse effects …

Discussion Amiodarone is a commonly used antiarrhythmic. It is associated with
extracardiac side effects, including asymptomatic hepatic dysfunction in 15–40% of patients …

Fatal amiodarone-induced hepatotoxicity: a case report and literature review. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …